Company	Price	Valuation					Profitability					Cash & leverage					Quality				Rating
		P/E	P/B	P/S	EV / EBITDA	DCF upside	Gross margin	Operating margin	Net margin	ROE	ROIC	FCF yield	Debt / equity	Net debt / EBITDA	Interest coverage	Current ratio	Dividend yield	Piotroski (0-9)	Altman Z	Rating score (1-5)
BVSthis companyBioventus Inc.	$10.87	21.88×	2.69×	0.87×	7.62×	-120.1%	67.3%	10.3%	4.0%	12.3%	10.8%	14.4%	1.69×	2.62×	2.21×	1.7×	0.0%	7	2.15	4	A-
ANIKAnika Therapeutics, Inc.	$14.53	-12.64×	0.96×	1.22×	-29.78×	-96.9%	56.6%	-9.8%	-9.6%	-7.6%	-6.5%	3.2%	0.18×	8.73×	0×	4.72×	0.0%	5	4.93	2	B-
BBLGBone Biologics Corporation	$0.37	-0.55×	0.32×	0×	1.17×	1037.0%	0.0%	0.0%	0.0%	-57.8%	-60.2%	-158.0%	0×	1.72×	0×	13.85×	0.0%	1	-18.45	2	B-
IARTIntegra LifeSciences Holdings Corporation	$13.71	-1.85×	0.91×	0.58×	-8.46×	77.8%	51.7%	4.2%	-31.6%	-49.5%	1.9%	-4.7%	1.95×	-5.53×	0.79×	2.54×	0.0%	7	1.31	3	B
MDXGMiMedx Group, Inc.	$3.32	20.52×	3.9×	2.39×	10.33×	13.9%	82.6%	15.3%	11.6%	18.9%	16.7%	7.3%	0.09×	-1.73×	35.83×	4.32×	0.0%	4	6.57	2	C
OFIXOrthofix Medical Inc.	$7.04	-6.65×	1.34×	0.74×	75.69×	-1046.3%	67.1%	-8.3%	-11.2%	-20.5%	-10.0%	-0.2%	0.51×	14.82×	-3.92×	2.45×	0.0%	5	1.04	2	C
Peer median	—	-1.85×	0.96×	0.74×	1.17×	13.9%	56.6%	0.0%	-9.6%	-20.5%	-6.5%	-0.2%	0.18×	1.72×	0×	4.32×	0.0%	5	1.31	2	—